RE:Going down to 0 hahaha with 480 million in cashYou are one of the few members on this board with any sense. You will be very rich one day if you aren't already.
fundtrader wrote:
sure it is..80 % of amco drugs costs less then 6.. 6 billion in deals in the past 2 years..880 million in revenue with adjusted ebidita over 520 million. 60 new drugs launches..new photofrin drug could generate 10% of cxr revenue in 2018 with new approvals shortly and now with cash in hand they could buy companies to add to revenue..man hope longs dint sell on this 5$ wall break..holding long for another year at least buying more everyday..couldnt give 2 shits what happens with share price..let it get to 3$ us..will buy more then again